LIHIT LAB., INC. (JP:7975)
:7975
Want to see JP:7975 full AI Analyst Report?
Top Page
LIHIT LAB., INC.
(7975)
Select Model
Select Model
Rating:47Neutral
Price Target:
¥1,159.00
▼(-7.06% Downside)
Action:ReiteratedDate:04/10/26
The score is held down primarily by inconsistent profitability and weak/volatile cash generation (including negative free cash flow in multiple years and a large deficit in 2026), despite a solid, low-leverage balance sheet. Technicals add caution due to a below-average trend and negative MACD, while valuation is mixed with a modest dividend yield offset by a relatively high P/E given recent earnings instability.
Positive Factors
Conservative balance sheet
The company’s conservative balance sheet—with modest debt and a sizable equity base—provides durable financial flexibility. Low leverage reduces refinancing risk and preserves capacity for targeted capital spending or working-capital needs, cushioning profit and cash-flow volatility over the next several months.
Negative Factors
Volatile and negative free cash flow
Repeated negative free cash flow and a very large 2026 deficit indicate weak cash conversion and potential structural funding pressure. Persistent FCF shortfalls force reliance on financing or asset moves, constraining reinvestment, dividend sustainability and strategic flexibility over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
The company’s conservative balance sheet—with modest debt and a sizable equity base—provides durable financial flexibility. Low leverage reduces refinancing risk and preserves capacity for targeted capital spending or working-capital needs, cushioning profit and cash-flow volatility over the next several months.
Read all positive factors
LIHIT LAB., INC. (7975) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥3.92B
Dividend Yield2.03%
Average Volume (3M)833.00
Price to Earnings (P/E)27.0
Beta (1Y)0.13
Revenue Growth-1.04%
EPS Growth-83.70%
CountryJP
Employees592
SectorIndustrials
Sector Strength72
IndustryBusiness Equipment & Supplies
Share Statistics
EPS (TTM)11.48
Shares Outstanding3,815,700
10 Day Avg. Volume1,000
30 Day Avg. Volume833
Financial Highlights & Ratios
PEG Ratio-0.75
Price to Book (P/B)0.38
Price to Sales (P/S)0.46
P/FCF Ratio-3.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
LIHIT LAB., INC. Business Overview & Revenue Model
Company Description
Lihit Lab.,Inc. manufactures and sells office supplies in Japan and internationally. It offers punch files, Z-type, slide bar and bookbinding, clear holder, pocket holder, and other files; clear books; binders; card, postcard, photo album, and pas...
How the Company Makes Money
null...
LIHIT LAB., INC. Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
74
Positive
Cash Flow
33
Negative
| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.32B | 9.12B | 9.22B | 8.80B | 8.51B | 8.69B |
| Gross Profit | 3.13B | 3.00B | 2.88B | 2.52B | 2.50B | 2.90B |
| EBITDA | 762.98M | 306.06M | 822.07M | 174.54M | 261.38M | 725.53M |
| Net Income | 400.39M | 67.07M | 411.57M | -93.73M | -24.41M | 262.51M |
Balance Sheet | ||||||
| Total Assets | 12.88B | 13.52B | 13.43B | 13.12B | 13.03B | 13.62B |
| Cash, Cash Equivalents and Short-Term Investments | 1.32B | 728.51M | 2.33B | 1.24B | 1.08B | 2.26B |
| Total Debt | 280.50M | 282.00M | 437.50M | 751.50M | 445.00M | 698.00M |
| Total Liabilities | 2.34B | 2.54B | 2.79B | 2.88B | 2.81B | 3.51B |
| Stockholders Equity | 10.54B | 10.98B | 10.64B | 10.24B | 10.22B | 10.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.36B | 17.92M | -196.64M | -825.63M | 608.64M |
| Operating Cash Flow | 0.00 | 47.73M | 290.49M | 663.33M | -745.70M | 720.74M |
| Investing Cash Flow | 0.00 | -1.40B | 1.18B | -726.91M | -112.96M | -127.15M |
| Financing Cash Flow | 0.00 | -241.69M | -400.05M | 220.14M | -339.35M | -139.16M |
LIHIT LAB., INC. Technical Analysis
Negative
1247.00
Price Trends
1210.79
Negative
1220.79
Negative
1186.34
Negative
Market Momentum
-9.19
Negative
42.43
Neutral
19.91
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7975, the sentiment is Negative. The current price of 1247 is above the 20-day moving average (MA) of 1169.90, above the 50-day MA of 1210.79, and above the 200-day MA of 1186.34, indicating a bearish trend. The MACD of -9.19 indicates Negative momentum. The RSI at 42.43 is Neutral, neither overbought nor oversold. The STOCH value of 19.91 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7975.
LIHIT LAB., INC. Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥131.94B | 12.67 | ― | 2.09% | 0.66% | -30.89% | |
71 Outperform | ¥168.16B | 15.37 | ― | 2.56% | 0.18% | -18.55% | |
64 Neutral | ¥347.53B | 9.14 | 8.83% | 2.33% | 7.82% | 13.39% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥22.78B | 17.75 | ― | 1.69% | -2.48% | 161.85% | |
57 Neutral | ¥37.98B | 16.66 | ― | 1.77% | 2.23% | -26.25% | |
47 Neutral | ¥3.92B | 27.03 | ― | 2.03% | -1.04% | -83.70% |
* Industrials Sector Average
JP:7975
LIHIT LAB., INC.
1,155.00
78.36
7.28%
JP:7984
Kokuyo Co
809.90
89.92
12.49%
JP:4218
Nichiban Co., Ltd.
1,833.00
-141.13
-7.15%
JP:7846
Pilot Corporation
4,800.00
986.34
25.86%
JP:7962
King Jim Co., Ltd.
800.00
-53.97
-6.32%
JP:7976
Mitsubishi Pencil Company, Limited
2,547.00
398.44
18.54%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.